We later analyzed the detailed mechanism and showed that RhoA-MKL1-SRF signaling was involved in this ACTA1 inhibition by PAX3-FOXO1 in ARMS cells. This evidence concerns the gene SRF and alveolar rhabdomyosarcoma.